Cardiff Lexington Signs LOI for Up to $104 Million Musculoskeletal Healthcare Acquisition
Cardiff Lexington (CDIX) has signed a letter of intent to acquire a multi-location musculoskeletal healthcare platform in a deal valued up to $104 million. The transaction includes $30 million in cash at closing, along with $10 million in unsecured notes and preferred equity. This acquisition is expected to expand Cardiff Lexington's presence in the healthcare sector by adding specialized services focused on musculoskeletal care. The proposed deal highlights a strategic move into a growing segment of the healthcare industry that addresses chronic pain management and orthopedic treatments, which are increasingly in demand due to aging populations and rising prevalence of related conditions. The acquisition could enhance Cardiff Lexington's revenue streams through diversified service offerings across multiple locations. From a market perspective, this development may signal confidence from investors regarding the company’s long-term growth strategy.
Tickers: $CDIX
Topics: Healthcare M&A